Scientists Try to Unravel the Riddle of Too Much

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone

Scientists Try to Unravel the Riddle of Too Much Sleep

Getting too little sleep is bad for your health. But getting too much—as wonderful as it may sound to some—can be problematic too.

Getting too little sleep is bad for your health, but getting too much can be problematic. WSJ's Melinda Beck and Emory University sleep researcher Dr. David Rye have details on Lunch Break. Photo: Courtesy of Anna Sumner.

The powerful need to nap during the day can be a warning sign of many health issues, from diabetes to depression, low thyroid or obstructive sleep apnea. When doctors rule out such explanations, it is called "primary hypersomnia," an umbrella term for several conditions that make sufferers crave sleep, despite getting 70 hours or more per week. One of the best known is narcolepsy, a neurological disorder that causes sudden, irresistible bouts of daytime dozing. Other forms aren't well understood.

Recently, researchers at Emory University in Atlanta have begun to unravel the mystery of this often-debilitating condition. They've found that some sufferers have a substance in their cerebrospinal fluid that acts like a natural sleeping pill. They think as many as 1 in 800 Americans may have the substance and that it may be a factor in other conditions that involve excessive drowsiness.

Many people with hypersomnia go undiagnosed, experts say. The excessive sleep urges often begin in late adolescence, and are easy to confuse with typical teenage sleep issues.

Raymond McCrea Jones for The Wall Street Journal

After Anna Sumner, an Atlanta attorney, suffered sleeping binges of more than 50 hours at a stretch, doctors discovered the culprit: a substance in her spinal fluid.

"It tends to hit people in their young, formative years when they are trying to get started in a profession or having a family," says Dr. David Rye, a professor of neurology at Emory and lead author of a paper on the discovery, published last month in the journal Science Translational Medicine. "A lot of them get dismissed as lazy, or as drug seekers."

Researchers now know that this condition "is something real," says Andrew Jenkins, an associate professor of neuroscience, molecular and system pharmacology at Emory. "We know why you're sleepy—your brain is sedating itself," he says.

The Emory team discovered the mysterious sleep agent, or "somnogen," when Anna Sumner, a young Atlanta attorney, sought help at the sleep clinic in 2005. After napping prodigiously through college and law school (she says roommates at Princeton made up stories to cover for her), her sleep cravings began intensifying in her 20s. At one point, she says, "I'd go to bed one night and wake up two days later."

When the spells' frequency increased from once every two months to once a week, she says, "I had to take a leave from work."

After standard treatment with stimulants stopped working, the Emory doctors discovered that a substance in Ms. Sumner's spinal fluid was supercharging GABA, a natural sleep-inducing brain chemical. The effect was like being under constant twilight sedation. "I don't know how she was able to function," says Dr. Jenkins, whose team decided to try treating her with a drug called flumazenil, used in emergency rooms to counteract overdoses of sedatives. After several days in the hospital on an IV drip, she suddenly opened her eyes and said, "I feel alive!"

She has been taking it in a specially made lozenge form since then, and is feeling happily alert—and just learned she will be made a partner next year.

The Emory researchers think this same sleep-inducing substance in spinal fluid may play a role in other conditions that involve excessive drowsiness. They still haven't identified the exact chemical. But they can test for it in other patients by watching how their spinal fluid acts on GABA in a laboratory setting.

So far, they have found the somnogen in the spinal fluid of 32 sleep-clinic patients. They tested flumazenil on seven of them and found that it restored alertness in all of them to differing degrees. "I think what we've discovered is the biology. And the question is, what syndromes is it relevant to?" says Dr. Rye.

One may be narcolepsy, those irresistible sleep attacks that can hit multiple times a day. Sufferers go into REM sleep immediately when they nap, and tend to wake up refreshed—at least temporarily. Some also have cataplexy, which involves sudden loss of muscle control.

A rarer form of hypersomnia, called Kleine-Levin syndrome, occurs almost exclusively in teenage boys. Sufferers sleep for several days at a time, and when they wake up, they are irritable, ravenously hungry and sometimes hypersexual.

Dr. Rye and his colleagues have found the sleep-inducing spinal fluid in patients previously diagnosed with both conditions. They are also working with the Centers for Disease Control and Prevention and hope to test for it in blood samples from people with chronic fatigue syndrome. They are also tracking how it travels in families. One-third of the 32 patients in the study have relatives with excessive sleepiness to varying degrees.

Since the study appeared, they have been fielding calls from other patients and sleep clinics—95 last week alone. "There is a huge unmet need of people who identify with Anna," says Dr. Rye, referring to Ms. Sumner.

Traditional treatments for hypersomnia, including stimulants such as Provigil, have proven to be effective sometimes with conditions like narcolepsy. But side effects can include a feeling of being "revved up."

Flumazenil, the drug used to treat Ms. Sumner, is proving hard to come by. Since it went off patent in 2008, the amount of the generic version produced annually for all of North America—enough to counteract 10,000 sedative overdoses—would supply only a handful of patients like Ms. Sumner, Emory researchers say.

But they are investigating other drugs that may have the same effect. Past research shows that one class of antibiotics may have a similar action at GABA receptors.

Of course, the vast majority of people with excessive daytime sleepiness don't have hypersomnia—most just don't get enough sleep at night. Shelby Harris, director of the Behavioral Sleep Medicine Program at Montefiore Medical Center in Bronx, N.Y., recommends that patients get at least eight hours of sleep nightly for two weeks before exploring other causes. "Make sleep a priority, and if that fixes it, great," she says. "If not, mention it to your primary-care doctor."

Indeed, many underlying health issues can also make people drowsy, including thyroid conditions, hormonal changes, vitamin deficiencies and infections; some can be ruled in or out with blood tests. Sleepiness is also a side effect of many medications, alcohol use or psychiatric conditions.

So many factors can affect alertness and energy levels, and they vary so much over the life span, that many people with sleep disorders never realize they have one. They often mask it with coffee or view drowsiness as just a fact of life.

Dr. Harris also recommends that people who think they are excessively sleepy keep track of when the drowsiness occurs. Nodding off after dinner or wanting to sleep till noon could indicate circadian rhythm disorders. "Afternoon slump"—the urge to nap at your desk after lunch—is a normal dip in the body's 24-hour clock.

"I tell patients to go out and take a walk when that happens," says Dr. Harris. "Being exposed to light can be more alerting than a cup of coffee."

Write to Melinda Beck at melinda.beck@wsj.com

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 0

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 5

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 0

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 0

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 5

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 6

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 0

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

AI Alliance Introduces Game-Changing Tools and Expands

Updated Category News Views 289

AI Alliance Launches Innovative Programming Language and Framework Today marked a significant advancement in the world of artificial intelligence as the AI Alliance, a global non-profit organization committed to the evolution of open-source AI, unveiled groundbreaking initiatives. The introduction of Dana, an AI-powered programming language, alongside the OpenDXA agent...

Continue Reading
FDA Approves Repatha for Adults with High LDL-C Risks

Updated Category News Views 245

FDA Broadens Repatha Approval for Cardiovascular Risk Recently, the FDA has expanded the therapeutic indications for Repatha (evolocumab), allowing it to be prescribed to adults at a heightened risk of major adverse cardiovascular events (MACE) due to uncontrolled low-density lipoprotein cholesterol (LDL-C), often referred to as 'bad cholesterol.' This significant update...

Continue Reading
Nikola Corp Strengthens Financial Strategy with Updated Equity Deal

Updated Category News Views 116

Nikola Corporation's Strategic Financial Update Nikola Corporation (NASDAQ:NKLA), renowned for its commitment to zero-emission vehicle manufacturing, has made significant adjustments to its equity distribution agreement with Citigroup Global Markets Inc. This change was detailed in a recent filing, affirming the company's proactive approach to managing its financial...

Continue Reading
Exploring the Future of the Emergency Food Market Growth

Updated Category News Views 243

Understanding the Emergency Food Market Expansion The global emergency food market is on the brink of a significant transformation as it is projected to grow by an impressive USD 3.20 billion over the period from 2024 to 2028. With a compound annual growth rate (CAGR) of approximately 7.35%, this market is witnessing a shift driven by the organized retail sector's growth...

Continue Reading
Innovative Robotics: KEENON Launches Humanoid and Lawn Mower

Updated Category News Views 166

KEENON Robotics Makes Waves at CES with New Innovations At the recent tech event, KEENON Robotics, a pioneer in the field of service robotics, took center stage by unveiling its latest creations: the humanoid robot XMAN-R1 and the fully autonomous lawn mower known as KEENMOW K1. This showcase reflects KEENON's commitment to innovation and its mission to improve everyday...

Continue Reading